UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

~~CURRENT~~Current ~~REPORT~~Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~Pursuant~~Date toof ~~Section~~Report 13(Date orof ~~15(d~~earliest event reported): ofSeptember 7, ~~the~~2004

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 21, 2004

ENDOCARDIAL SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

Delaware	0-22233	41-1724963
(State or other jurisdiction of incorporation)	(Commission ~~File~~file ~~Number~~number)	(~~IRS~~I.R.S. Employer Identification No.)
1350 Energy Lane, Suite 110, St. Paul, Minnesota		55108
(Address of principal executive offices)		(Zip Code)

~~1350~~(651) ~~Energy Lane, Suite 110, St. Paul, Minnesota 55108~~523-6900

(~~Address of~~Registrant’s ~~principal~~telephone ~~executive~~number, ~~offices~~including area code)

Registrant’s telephone number, including area code: (651) 523-6900

Not Applicable

(Former name or former address, if changed since last report)

~~Item~~Check the appropriate box below if the Form ~~7. Financial~~8-K ~~Statements~~filing ~~and~~is ~~Exhibits~~intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (c17 CFR 230.425) ~~Exhibits~~

Exhibit No.		Description
99.1		Press release of Endocardial Solutions, Inc., dated April 21, 2004, reporting financial results for the first quarter of 2004

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

~~Item~~o ~~12. Results~~Pre-commencement ofcommunications pursuant to Rule ~~Operations~~14d-2(b) ~~and~~under ~~Financial~~the ~~Condition~~Exchange Act (17 CFR 240.14d-2(b))

~~Furnished herewith~~o asPre-commencement ~~Exhibit~~communications ~~99.1~~pursuant ~~and~~to ~~incorporated by reference herein is the text of~~Rule ~~Endocardial~~13e-4(c) ~~Solutions,~~under ~~Inc.’s announcement regarding earnings results for~~ the ~~first~~ ~~quarter~~Exchange ~~ended~~Act ~~March~~(17 ~~31,~~CFR ~~2004, as presented in a press release of April 21, 2004~~240.13e-4(c))

2Item 1.01. Entry into a Material Definitive Agreement.

~~Pursuant~~On September 7, 2004, Endocardial Solutions, Inc.(the “Company”) toentered into a Change in Control Agreement with Patrick Wethington, the ~~requirements~~Company’s Vice President Worldwide Sales. This agreement provides for the payment of 12 months base salary to Mr. Wethington if his employment with the ~~Securities~~Company ~~Exchange~~terminates ~~Act~~under certain circumstances following a change in control. The terms of ~~1934,~~this agreement are substantially similar to the ~~registrant~~terms ~~has~~set forth in the ~~duly~~Form ~~caused~~of ~~this~~Change ~~Report~~in Control Agreement filed as Exhibit 10.25 to bethe ~~signed~~Company’s Annual Report on ~~its~~Form ~~behalf~~10-K byfor the ~~undersigned~~year ~~hereunto duly~~ended ~~authorized~~December 31, 2000 (File No. 0-22233)).

Date: April 22, 2004
	ENDOCARDIAL SOLUTIONS, INC.
	By:	/s/ J. Robert Paulson, Jr.
		J. Robert Paulson, Jr.
		Chief Financial Officer

SIGNATURE

3Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

~~INDEX TO~~Date: September 13, ~~EXHIBITS~~2004

Exhibit No.		Description
99.1		Press release of Endocardial Solutions, Inc., dated April 21, 2004, reporting financial results for the first quarter of 2004

	ENDOCARDIAL SOLUTIONS, INC.


	By:	/s/ J. Robert Paulson, Jr.
		Name: J. Robert Paulson, Jr.
		Title: Chief Financial Officer

Filing Compare · ENDOCARDIAL SOLUTIONS INC